TassinariD., SartoriS., TamburiniE.Transdermal fentanyl as a front-line approach to moderate-severe pain: A meta-analysis of randomized clinical trials.J Palliat Care2009; 25(3): 172–180.
2.
AhmedzaiS., BrooksD., on behalf of the TTS-Fentanyl Comparative Trial Group. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy and quality of life.J Pain Symptom Manage1997; 13(5): 254–261.
3.
AllanL., HaysH., JensenN.H.Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.BMJ2001; 322(7295): 1154–1158.
4.
AllanL., RicharzU., SimpsonK.Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain.Spine2005; 30(22): 2484–2490.
5.
WongJ.O.N., ChiuG.L., TsaoC.J.Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain.Acta Anaesthesiol Sin1997; 35(1): 25–32.
6.
van SeventerR., SmitJ.M., SchipperR.M.Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.Curr Med Res Opin2003; 19(6): 457–469.
7.
Als-NielsenB., ChenW., GluudC.Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?JAMA2003; 290(7): 921–928.
